Fen Wang

11.5k total citations · 3 hit papers
277 papers, 7.5k citations indexed

About

Fen Wang is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Fen Wang has authored 277 papers receiving a total of 7.5k indexed citations (citations by other indexed papers that have themselves been cited), including 113 papers in Molecular Biology, 56 papers in Oncology and 54 papers in Surgery. Recurrent topics in Fen Wang's work include Fibroblast Growth Factor Research (26 papers), Cancer, Hypoxia, and Metabolism (17 papers) and Epigenetics and DNA Methylation (15 papers). Fen Wang is often cited by papers focused on Fibroblast Growth Factor Research (26 papers), Cancer, Hypoxia, and Metabolism (17 papers) and Epigenetics and DNA Methylation (15 papers). Fen Wang collaborates with scholars based in China, United States and Canada. Fen Wang's co-authors include Wallace L. McKeehan, Chengliu Jin, Chaofeng Yang, Xuefeng Yu, Xiaoli Shi, Yongli Yan, Shujun Zhang, Huihui Ren, Kun Dong and Jianping Jia and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Fen Wang

266 papers receiving 7.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dementia in China: epidemiology, clinical management, and research advances

2019 576 citations Fen Wang et al. profile →
Clinical characteristics and outcomes of patients with severe covid-19 with diabetes

2020 408 citations Yongli Yan, Yan Yang et al. BMJ Open Diabetes Research & Care profile →
Single-cell transcriptome analysis revealed a suppressive tumor immune microenvironment in EGFR mutant lung adenocarcinoma

2022 120 citations Xue‐Wu Wei, Zhihong Chen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fen Wang China	43	3.6k	1.2k	1.2k	969	677	277	7.5k
Hua Liu China	52	4.3k 1.2×	1.0k 0.9×	1.4k 1.2×	579 0.6×	648 1.0×	373	9.7k
Fahd Al‐Mulla Kuwait	42	3.0k 0.8×	917 0.8×	832 0.7×	378 0.4×	555 0.8×	328	6.9k
Yan Huang China	34	2.7k 0.7×	864 0.7×	1.7k 1.4×	556 0.6×	394 0.6×	104	5.3k
Jin Wang China	49	4.3k 1.2×	1.6k 1.3×	2.9k 2.4×	850 0.9×	819 1.2×	342	9.4k
Wei Li China	51	5.5k 1.5×	896 0.7×	995 0.8×	582 0.6×	681 1.0×	335	10.2k
Song Chen China	43	2.7k 0.8×	698 0.6×	841 0.7×	802 0.8×	1.2k 1.8×	329	7.5k
Yoshitaka Isaka Japan	53	4.1k 1.2×	759 0.6×	634 0.5×	1.2k 1.3×	1.3k 2.0×	395	12.2k
Lin Li China	44	4.2k 1.2×	658 0.5×	530 0.4×	912 0.9×	369 0.5×	349	8.8k
Eun Young Kim South Korea	47	2.9k 0.8×	1.1k 0.9×	530 0.4×	1.4k 1.4×	1.0k 1.5×	357	8.3k
Sheng Li China	43	2.7k 0.8×	889 0.7×	1.2k 1.0×	1.2k 1.2×	1.0k 1.5×	389	8.0k

Countries citing papers authored by Fen Wang

Since Specialization

Citations

This map shows the geographic impact of Fen Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fen Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fen Wang more than expected).

Fields of papers citing papers by Fen Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fen Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fen Wang. The network helps show where Fen Wang may publish in the future.

Co-authorship network of co-authors of Fen Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Fen Wang. A scholar is included among the top collaborators of Fen Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fen Wang. Fen Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Fen, et al.. (2024). Salidroside promotes liver regeneration after partial hepatectomy in mice by modulating NLRP3 inflammasome-mediated pyroptosis pathway. Biochemical and Biophysical Research Communications. 735. 150678–150678.

Wei, Xue‐Wu, Xue Fan, Chong‐Rui Xu, et al.. (2024). Redox ^high phenotype mediated by KEAP1/STK11/SMARCA4/NRF2 mutations diminishes tissue-resident memory CD8+ T cells and attenuates the efficacy of immunotherapy in lung adenocarcinoma. OncoImmunology. 13(1). 2340154–2340154. 11 indexed citations

Zhan, Yuan, Fen Wang, Xian Wu, et al.. (2024). Hypothyroidism Promotes Microglia M1 Polarization by Inhibiting BDNF-Promoted PI3K-Akt Signaling Pathway. Neuroendocrinology. 115(1). 34–47. 1 indexed citations

Wang, Chen, Zongwei Lin, Hui Zhang, et al.. (2023). Dose Titration of Sacubitril/Valsartan for Heart Failure with Reduced Ejection Fraction: A Real-World Study. ESC Heart Failure. 10(3). 1961–1971. 11 indexed citations

Cai, Ting, et al.. (2023). The role of endoscopic ultrasound-guided fine-needle aspiration/biopsy in the diagnosis of mediastinal lesions. Frontiers in Surgery. 9. 1065070–1065070. 1 indexed citations

Wang, Fen, et al.. (2023). Adipocyte-derived CCDC3 promotes tumorigenesis in epithelial ovarian cancer through the Wnt/ß-catenin signalling pathway. Biochemistry and Biophysics Reports. 35. 101507–101507. 1 indexed citations

Sun, Zhengxu, Yan Yuan, Zifeng Li, et al.. (2022). Monocytic myeloid-derived suppressive cells mitigate over-adipogenesis of bone marrow microenvironment in aplastic anemia by inhibiting CD8+ T cells. Cell Death and Disease. 13(7). 620–620. 10 indexed citations

Wang, Fen, Feng Jin, Boran Cheng, et al.. (2021). The real-world efficacy and safety of anlotinib in advanced non-small cell lung cancer. Journal of Cancer Research and Clinical Oncology. 148(7). 1721–1735. 8 indexed citations

Yan, Yongli, Yan Yang, Fen Wang, et al.. (2020). Clinical characteristics and outcomes of patients with severe covid-19 with diabetes. BMJ Open Diabetes Research & Care. 8(1). e001343–e001343. 408 indexed citations breakdown →

10.

Druc, Isabelle, et al.. (2018). A preliminary assessment of the organization of ceramic production at Liangchengzhen, Rizhao, Shandong: Perspectives from petrography. Journal of Archaeological Science Reports. 18. 222–238. 17 indexed citations

11.

Wang, Fen. (2014). Clinical observation of oxaliplatin-based regimen for sorafenib-resistant advanced primary liver carcinoma. Chinese Clinical Oncology. 2 indexed citations

12.

Wang, Fen. (2014). Therapeutic effects of oxcarbazepine in children with partial seizures of epilepsy. 1 indexed citations

13.

Wang, Fen, Zhaoxia Du, Yang Yang, et al.. (2014). Zinc Finger DHHC-Type Containing 13 Regulates Fate Specification of Ectoderm and Mesoderm Cell Lineages by Modulating Smad6 Activity. Stem Cells and Development. 23(16). 1899–1909. 12 indexed citations

14.

Yang, Feng, Yongyou Zhang, Steven J. Ressler, et al.. (2013). FGFR1 Is Essential for Prostate Cancer Progression and Metastasis. Cancer Research. 73(12). 3716–3724. 82 indexed citations

15.

Wang, Fen. (2013). In vitro screen of anti-Staphylococcus aureus activity of 20 kinds of heatclearing and toxicity-removing Chinese herbal medicines. 1 indexed citations

16.

Valiyeva, Fatma, Fei Jiang, Madeleine Moussa, et al.. (2011). Characterization of the Oncogenic Activity of the Novel TRIM59 Gene in Mouse Cancer Models. Molecular Cancer Therapeutics. 10(7). 1229–1240. 40 indexed citations

17.

Tang, Cong, Jinghang Xie, Fen Wang, et al.. (2009). Downregulation of survivin and activation of caspase-3 through the PI3K/Akt pathway in ursolic acid-induced HepG2 cell apoptosis. Anti-Cancer Drugs. 20(4). 249–258. 85 indexed citations

18.

Wang, Fen. (2008). Effect of TACE with β-elemene and Lipiodol on Apoptosis and Proliferation of VX2 Carcinoma of Rabbits. 1 indexed citations

19.

Sutherland, Brent W., Sue E. Knoblaugh, Paula Kaplan‐Lefko, et al.. (2008). Conditional Deletion of Insulin-like Growth Factor-I Receptor in Prostate Epithelium. Cancer Research. 68(9). 3495–3504. 54 indexed citations

20.

Wang, Fen. (2008). The effection of Tangnai-Kang for Insulin signal-transduction in Spontaneous Type 2 Diabetic animal KKAy mouse. Zhongguo shiyan fangjixue zazhi. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact